» Articles » PMID: 33145717

Changes in Bone Mineral Density After Weight Loss Due to Metabolic Surgery or Lifestyle Intervention in Obese Patients

Overview
Journal Obes Surg
Date 2020 Nov 4
PMID 33145717
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Metabolic surgery and lifestyle intervention are two common methods used to treat obesity, but the effects of weight loss on bone mineral density (BMD) remain controversial. Our aim was to evaluate changes in BMD of the total hip, femoral neck, and lumbar spine after weight loss caused by metabolic surgery or lifestyle intervention.

Materials And Methods: We searched PubMed, Web of Science, and the Cochrane Library to identify relevant studies published before 5 August 2020. The primary outcomes, including the BMD of the total hip, femoral neck, and lumbar spine before and 12 months after metabolic surgery or lifestyle intervention, were extracted.

Results: A total of 19 studies with 1095 participants with obesity were included. Among them, 603 participants with obesity accepted metabolic surgery, while 492 accepted lifestyle intervention. At 12 months after weight loss, the BMD of the total hip decreased significantly in obese patients (mean difference [MD] = 0.06 g/cm; 95% confidence interval [CI] 0.03 to 0.08; I = 67%; P < 0.001), while the BMD of the lumbar spine did not significantly change (P > 0.05). In the subgroup analysis, the BMD of the femoral neck decreased significantly at 12 months in obese patients who underwent metabolic surgery (MD = 0.08 g/cm; 95% CI 0.04 to 0.13; I = 84%; P < 0.001), while it did not significantly change in obese patients who underwent lifestyle treatment (P > 0.05).

Conclusion: Regardless of whether the patients underwent metabolic surgery or lifestyle treatment, the BMD of the total hip significantly decreased in obese patients after weight loss. Different methods used to lose weight may have different effects on the BMD of the femoral neck. Prospective studies, preferably randomized controlled trials (RCTs), are still required to investigate whether the effects of the two treatments on bone metabolism are truly different.

Citing Articles

The Impact of Obesity Treatments on Bone Health: Insights from Recent Research.

Heo J J Obes Metab Syndr. 2025; 34(1):1-3.

PMID: 39814406 PMC: 11799602. DOI: 10.7570/jomes25001.


Effects of Anti-Obesity Strategies on Bone Mineral Density: A Comprehensive Meta-Analysis of Randomized Controlled Trials.

Kim M, Kim S, Jung H, Jung C, Lee W, Cho Y J Obes Metab Syndr. 2025; 34(1):41-53.

PMID: 39800333 PMC: 11799600. DOI: 10.7570/jomes24009.


The long-term effect of intentional weight loss on changes in bone mineral density in persons with type 2 diabetes: results from the Look AHEAD randomized trial.

Johnson K, Anderson A, Beavers K, Crandall C, Hazuda H, Lewis C Arch Osteoporos. 2023; 18(1):97.

PMID: 37452151 PMC: 10348976. DOI: 10.1007/s11657-023-01303-0.


Weight Loss Interventions and Skeletal Health in Persons with Diabetes.

Zhao Q, Khedkar S, Johnson K Curr Osteoporos Rep. 2022; 20(5):240-248.

PMID: 36040543 PMC: 9522834. DOI: 10.1007/s11914-022-00744-9.


The association between body fat distribution and bone mineral density: evidence from the US population.

Ma M, Liu X, Jia G, Geng B, Xia Y BMC Endocr Disord. 2022; 22(1):170.

PMID: 35787696 PMC: 9254427. DOI: 10.1186/s12902-022-01087-3.

References
1.
Muller-Stich B, Senft J, Warschkow R, Kenngott H, Billeter A, Vit G . Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg. 2014; 261(3):421-9. DOI: 10.1097/SLA.0000000000001014. View

2.
Rubino F, Nathan D, Eckel R, Schauer P, Alberti K, Zimmet P . Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016; 39(6):861-77. DOI: 10.2337/dc16-0236. View

3.
Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J . Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993; 307(6912):1111-5. PMC: 1679116. DOI: 10.1136/bmj.307.6912.1111. View

4.
Grethen E, Hill K, Jones R, Cacucci B, Gupta C, Acton A . Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab. 2012; 97(5):1655-62. PMC: 3339883. DOI: 10.1210/jc.2011-2280. View

5.
Yang S, Shen X . Association and relative importance of multiple obesity measures with bone mineral density: the National Health and Nutrition Examination Survey 2005-2006. Arch Osteoporos. 2015; 10:14. DOI: 10.1007/s11657-015-0219-2. View